News

For patients undergoing breast radiotherapy to treat their cancer, receiving a high-quality standard of care is important – particularly given they receive treatment over several sessions. 

However, this consistency can be challenging to maintain as each patient’s body is different. Positioning the breast accurately is key to ensuring the radiation targets the right area, yet variations in body shape and size can make this difficult. 

Dr. David Huntsman has been awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research by the Ovarian Cancer Research Alliance (OCRA), recognizing his findings that have profoundly impacted the treatment of certain ovarian cancer subtypes.

Dr. Marcel Bally, distinguished scientist, Basic and Translational Research at BC Cancer Research Institute and professor at UBC’s Department of Pathology and Laboratory Medicine, has been awarded new funding through Genome BC’s Genomics Applications Partnership Program (GAAP). 

Dr. Katey Enfield, scientist at the BC Cancer Research Institute, has been named one of seven emerging researchers across Canada to receive a 2026 Terry Fox New Investigator Award, a significant national recognition that supports early career scientists pursuing transformative cancer research. 

Investigators from BC Cancer – Prince George (Centre for the North) are co-authors on three international collaborative publications featured in the same issue of The Lancet Oncology.

Researchers at BC Cancer Research Institute, led by Dr. Bernie Eigl, director of the Provincial Clinical Trials Office, and Dr. Alex Wyatt, senior scientist and scientific director of the Cancer Genetics and Genomics Laboratory, examined whether a blood test that analyzes cancer-derived DNA found in the blood, called circulating tumour DNA (ctDNA), could help identify more patients with metastatic urothelial carcinoma – an aggressive form of bladder cancer – who are eligible for FGFR-targeted therapy.